
Reading Time: 2 minutesAmpio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, provides updates regarding the following clinical trials: Ampion Phase I clinical trial for intravenous (“IV”) treatment of COVID-19 patients:The initial safety Read more…
Recent Comments